Related Experiment Videos
Immunopathology of atopic keratoconjunctivitis
C S Foster1, B A Rice, J E Dutt
1Harvard Medical School, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston 02114.
Ophthalmology
|August 1, 1991
Summary
Atopic keratoconjunctivitis (AKC) involves significant T-cell and macrophage activation in the conjunctiva. Effective treatment for this chronic eye inflammation requires targeting these immune cells, not just mast cells.
Area of Science:
- Ophthalmology
- Immunology
- Cell Biology
Background:
- Atopic keratoconjunctivitis (AKC) is a chronic inflammatory eye condition.
- The specific cellular mechanisms driving conjunctival inflammation in AKC require further elucidation.
Purpose of the Study:
- To investigate the cellular composition and immune cell activation within conjunctival biopsies of patients with AKC.
- To compare these findings with healthy control subjects.
Main Methods:
- Conjunctival biopsies were obtained from 11 AKC patients and 13 healthy controls.
- Histological and immunohistochemical analyses were performed to identify and quantify immune cell populations.
Main Results:
- AKC conjunctiva showed goblet cell changes, epithelial abnormalities, and significant infiltration of T cells, macrophages, and dendritic cells.
- Elevated levels of activated T cells (CD25+) and a higher helper/suppressor T cell ratio were observed in AKC epithelium and substantia propria.
- Granuloma formation and increased inflammatory cell infiltration, including T cells, macrophages, and B cells, were prominent in the AKC substantia propria.
Conclusions:
- The chronic conjunctivitis in AKC is a complex immune process involving significant activation of T cells and macrophages.
- Therapeutic strategies for AKC should address these key inflammatory mediators beyond mast cells for successful long-term management.